Table 2.
Characteristic | Non-incidental (n=231) | Incidental (n=351) | P value |
Age (years) | 62 (33–92) | 65 (29–90) | 0.04 |
Gender | |||
Female | 77 (38.3) | 124 (61.7) | |
Male | 154 (40.4) | 227 (59.6) | 0.69 |
BMI | 28.3 (15.6–67.2) | 27.8 (17.2–57.7) | 0.38 |
Tumour size (path) (mm) | 75 (13–240) | 42 (11–170) | <0.01 |
Tumour size (CT) (mm) | 80 (16–250) | 44 (10–170) | <0.01 |
pT | |||
1a | 25 (12.8) | 170 (87.2) | |
1b | 48 (37.2) | 81 (62.8) | |
2 | 46 (60.5) | 30 (39.5) | |
3 | 101 (61.2) | 64 (38.8) | |
4 | 4 (100) | 0 (0) | |
X | 0 (0) | 2 (100) | |
Missing | 0 (0) | 1 (100) | |
NA* | 7 (70) | 3 (30) | <0.01 |
Grade | |||
1 | 6 (66.7) | 3 (33.3) | |
2 | 56 (35.9) | 100 (64.1) | |
3 | 93 (34.6) | 176 (65.4) | |
4 | 65 (75.6) | 21 (24.4) | |
Missing | 6 (26.1) | 17 (73.9) | |
NA* | 5 (12.8) | 34 (87.2) | <0.01 |
Stage | |||
I | 70 (21.6) | 254 (78.4) | |
II | 42 (60.9) | 27 (39.1) | |
III | 80 (58.4) | 57 (41.6) | |
IV | 39 (78) | 11 (22) | |
Missing | 0 (0) | 2 (100) | <0.01 |
Tumour subtype | |||
Clear cell | 186 (40.9) | 269 (59.1) | |
Papillary | 21 (35.6) | 38 (64.4) | |
Chromophobe | 19 (41.3) | 28 (58.7) | |
Unclassified | 5 (27.8) | 13 (72.2) | |
Other | 0 (0) | 3 (100) | 0.62 |
*Not applicable (NA), patients underwent biopsy only or tumour ablation.
BMI, body mass index.